Rosenberg, J., Petrylak, D., Abidoye, O., Van der Heijden, M., Hofman-Censits, J., Necchi, A., O'Donnell, P., Balmanoukian, A., Loriot, Y., Retz, M., Perez-Gracia, J., Dawson, N., Balar, A., Galsky, M., Fleming, M., Powles, T., Cui, N., Mariathasan, S., Fine, G., & Dreicer, R. (n.d.). 21LBA Atezolizumab in patients (pts) with locally-advanced or metastatic urothelial carcinoma (mUC): Results from a pivotal multicenter phase II study (IMvigor 210). European journal of cancer, 51, S720–. http://access.bl.uk/ark:/81055/vdc_100030687872.0x000063